摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-iodo-4-methylphenylacetic acid | 90585-28-7

中文名称
——
中文别名
——
英文名称
2-iodo-4-methylphenylacetic acid
英文别名
2-(2-iodo-4-methylphenyl)acetic acid
2-iodo-4-methylphenylacetic acid化学式
CAS
90585-28-7
化学式
C9H9IO2
mdl
——
分子量
276.074
InChiKey
WHUIDFGRGBZHMK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    356.1±27.0 °C(Predicted)
  • 密度:
    1.778±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-iodo-4-methylphenylacetic acid4-二甲氨基吡啶叔丁基锂盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 以 四氢呋喃正己烷二氯甲烷 为溶剂, 反应 4.0h, 生成 1,4-dimethyl-1,2-dihydrobenzocyclobuten-1-ol
    参考文献:
    名称:
    催化剂和条件控制下钴/铑催化的 C-C 裂解苯并环丁烯醇的多样化酰胺化
    摘要:
    使用二恶唑酮作为酰胺化试剂,实现了钴(III)和铑(III)催化的苯并环丁烯醇的区域和化学选择性酰胺化,通过苯并环丁烯醇的β-碳消除得到三类C-N偶联产物。Co(III)催化的偶联最初提供了可分离的邻- ( N-酰氨基)芳基甲基酮,其可以在条件控制下进一步环化为相应的吲哚衍生物。相比之下,在 Rh(III) 催化剂控制下实现了有效的逐步二酰胺化。化学选择性由催化剂和反应条件共同控制。
    DOI:
    10.1021/acs.orglett.3c01788
  • 作为产物:
    描述:
    盐酸高碘酸 作用下, 以 丙酮乙腈 为溶剂, 生成 2-iodo-4-methylphenylacetic acid
    参考文献:
    名称:
    Synthesis and biological evaluation of loxoprofen derivatives
    摘要:
    Non-steroidal anti-inflammatory drugs (NSAIDs) achieve their anti-inflammatory actions through an inhibitory effect on cyclooxygenase (COX). Two COX subtypes, COX-1 and COX-2, are responsible for the majority of COX activity at the gastrointestinal mucosa and in tissues with inflammation, respectively. We previously suggested that both gastric mucosal cell death due to the membrane permeabilization activity of NSAIDs and COX-inhibition at the gastric mucosa are involved in NSAID-induced gastric lesions. We have also reported that loxoprofen has the lowest membrane permeabilization activity among the NSAIDs we tested. In this study, we synthesized a series of loxoprofen derivatives and examined their membrane permeabilization activities and inhibitory effects on COX-1 and COX-2. Among these derivatives, 2-{4'-hydroxy-5-[(2-oxocyclopentyl)methyl]biphenyl-2-yl}propanoate 31 has a specificity for COX-2 over COX-1. Compared to loxoprofen, oral administration of 31 to rats produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that 31 is likely to be a therapeutically beneficial and safer NSAID. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.04.050
点击查看最新优质反应信息

文献信息

  • Enantioselective Allylic C−H Oxidation of Terminal Olefins to Isochromans by Palladium(II)/Chiral Sulfoxide Catalysis
    作者:Stephen E. Ammann、Wei Liu、M. Christina White
    DOI:10.1002/anie.201603576
    日期:2016.8.8
    The enantioselective synthesis of isochroman motifs has been accomplished by palladium(II)‐catalyzed allylic C−H oxidation from terminal olefin precursors. Critical to the success of this goal was the development and utilization of a novel chiral aryl sulfoxide‐oxazoline (ArSOX) ligand. The allylic C−H oxidation reaction proceeds with the broadest scope and highest levels of asymmetric induction reported
    异氰酸酯基序的对映选择性合成已通过(II)催化烯基CH从末端烯烃前体的氧化而完成。实现这一目标的关键是开发和利用新型手性芳基亚砜-恶唑啉(ArSOX)配体。与最宽的范围和不对称诱导最高平的烯丙基C-H的氧化反应的进行报告的日期(平均92%ee值,13点的例子具有大于90%的ee值)。
  • Synthesis of <i>N</i>-Glycosyl-2-oxindoles by Pd-Catalyzed N-Arylation of 1-Amidosugars
    作者:Boris Letribot、Wafa Redjdal、Belkacem Benmerad、Franck Le Bideau、Mouâd Alami、Samir Messaoudi
    DOI:10.1021/acs.orglett.0c01262
    日期:2020.6.5
    An efficient intramolecular Pd-catalyzed N-arylation of o-iodo-amidosugars for the synthesis of N-glycosylated oxindoles has been reported. The coupling reaction takes place in toluene and involves Pd(OAc)2/RuPhos catalytic systems in the presence of K2CO3. This versatile approach was extended successfully to the synthesis of other N-glycosylated heterocycles.
    已经报道了用于合成N-糖基化的羟吲哚的有效的分子内Pd催化的O--基糖的N-芳基化。偶联反应在甲苯中进行,并且涉及在K 2 CO 3存在下的Pd(OAc)2 / RuPhos催化体系。这种通用方法已成功扩展到其他N-糖基化杂环的合成。
  • Copper-Catalyzed Intramolecular Desymmetric Aryl CO Coupling for the Enantioselective Construction of Chiral Dihydrobenzofurans and Dihydrobenzopyrans
    作者:Wenqiang Yang、Yangyuan Liu、Shasha Zhang、Qian Cai
    DOI:10.1002/anie.201503882
    日期:2015.7.20
    O‐Heterocyclic structures such as 2,3‐dihydrobenzofurans are key motifs in many natural compounds and pharmaceuticals. Enantioselective formation of chiral dihydrobenzofurans and analogues was achieved through a copper‐catalyzed desymmetrization strategy with a chiral cyclic 1,2‐diamine. A broad range of substrates are compatible with this CuI‐diamine catalytic system and afford the desired coupling
    诸如2,3-二氢苯并呋喃之类的O杂环结构是许多天然化合物和药物中的关键基序。手性二氢苯并呋喃及其类似物的对映选择性形成是通过催化的手性环状1,2-二胺的去对称化策略实现的。各种各样的底物都可以与这种Cu I-二胺催化体系兼容,并在温和条件下以高收率和良好至优异的对映选择性提供具有手性叔或季碳中心的所需偶联产物。
  • Mercury in organic chemistry. 26. Synthesis of heterocycles via intramolecular solvomercuration of aryl acetylenes
    作者:Richard C. Larock、L. Wayne Harrison
    DOI:10.1021/ja00327a026
    日期:1984.7
  • Expedient Drug Synthesis and Diversification via ortho-C−H Iodination using Recyclable PdI<sub>2</sub> as the Precatalyst
    作者:Tian-Sheng Mei、Dong-Hui Wang、Jin-Quan Yu
    DOI:10.1021/ol1010483
    日期:2010.7.16
    Pd(II)-catalyzed ortho-C H iodination reactions of phenylacetic acid substrates have been achieved using recyclable Pdl(2) as the precatalyst. This class of substrates is incompatible with the classic amide formation/ortho-lithiation/iodination sequence. The power of this new technology is demonstrated by facile drug functionalization and drastically shortened syntheses of the drugs diclofenac and lumiracoxib.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫